Peptidomic profiling of human cerebrospinal fluid identifies YPRPIHPA as a novel substrate for prolylcarboxypeptidase

Proteomics

Volumn 10, Issue 15, 2010, Pages 2882-2886

  Zhao, Xuemei ^a   Southwick, Katie ^a   Cardasis, Helene L ^a   Du, Yi ^a   Lassman, Michael E ^a   Xie, Dan ^a   El Sherbeini, Mohamed ^a,b   Geissler, Wayne M ^a   Pryor, KellyAnn D ^a   Verras, Andreas ^a   Garcia Calvo, Margarita ^a   Shen, Dong Ming ^a   Yates, Nathan A ^a   Pinto, Shirly ^a   Hendrickon, Ronald C ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b KEAN UNIVERSITY   (United States)

Author keywords

Biomedicine; Cerebrospinal fluid; dMS; Endothelin B receptor like protein; Prolylcarboxypeptidase

Indexed keywords

ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR LIKE PROTEIN 2; PROLINE CARBOXYPEPTIDASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANGIOGENESIS; ARTICLE; BLOOD PRESSURE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; HUMAN; INFLAMMATION; PEPTIDOMICS; PRIORITY JOURNAL; PROTEIN ANALYSIS;

AMINO ACID SEQUENCE; CARBOXYPEPTIDASES; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; SEQUENCE ALIGNMENT; SUBSTRATE SPECIFICITY;

EID: 77955108541     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000145     Document Type: Article

References (22)

1. Yang, H. Y., Erdos, E. G., Chiang, T. S., New enzymatic route for the inactivation of angiotensin. Nature 1968, 218, 1224-1226.
2. Odya, C. E., Marinkovic, D. V., Hammon, K. J., Stewart, T. A. et al., Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney. J. Biol. Chem. 1978, 253, 5927-5931. (Pubitemid 9014225)
3. Shariat-Madar, Z., Mahdi, F., Schmaier, A. H., Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator. J. Biol. Chem. 2002, 277, 17962-17969. (Pubitemid 34967607)
4. Shariat-Madar, Z., Mahdi, F., Schmaier, A. H., Recombinant prolylcarboxypeptidase activates plasma prekallikrein. Blood 2004, 103, 4554-4561. (Pubitemid 38750184)
5. Sleat, D. E., Wang, Y., Sohar, I., Lackland, H. et al., Identification and validation of mannose 6-phosphate glycoproteins in human plasma reveal a wide range of lysosomal and non-lysosomal proteins. Mol. Cell Proteomics 2006, 5, 1942-1956.
6. Selvarajan, S., Lund, L. R., Takeuchi, T., Craik, C. S. et al., A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation. Nat. Cell Biol. 2001, 3, 267-275. (Pubitemid 32201322)
7. McCarthy, J. J., Meyer, J., Moliterno, D. J., Newby, L. K. et al., Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients. Hum. Genet. 2003, 114, 87-98.
8. Skidgel, R. A., Erdos, E. G., Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies. Peptides 2004, 25, 521-525.
9. Moreau, M. E., Garbacki, N., Molinaro, G., Brown, N. J. et al., The kallikrein-kinin system: current and future pharmacological targets. J. Pharmacol. Sci. 2005, 99, 6-38. (Pubitemid 41366887)
10. Shariat-Madar, Z., Rahimy, E., Mahdi, F., Schmaier, A. H., Overexpression of prolylcarboxypeptidase enhances plasma prekallikrein activation on Chinese hamster ovary cells. Am. J. Physiol. Heart Circ. Physiol. 2005, 289, H2697-H2703.
11. Yvan-Charvet, L., Even, P., Bloch-Faure, M., Guerre-Millo, M. et al., Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes 2005, 54, 991-999.
12. Lee, D. K., George, S. R., O'Dowd, B. F., Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity. Trends Pharmacol. Sci. 2006, 27, 190-194.
13. Higuchi, K., Masaki, T., Gotoh, K., Chiba, S. et al., Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. Endocrinology 2007, 148, 2690-2697. (Pubitemid 46984786)
14. Takahashi, N., Li, F., Hua, K., Deng, J. et al., Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin. Cell Metab. 2007, 6, 506-512. (Pubitemid 350163052)
15. Mallela, J., Perkins, R., Yang, J., Pedigo, S. et al., The functional importance of the N-terminal region of human prolylcarboxypeptidase. Biochem. Biophys. Res. Commun. 2008, 374, 635-640.
16. Mallela, J., Yang, J., Shariat-Madar, Z., Prolylcarboxypeptidase: a cardioprotective enzyme. Int. J. Biochem. Cell Biol. 2009, 41, 477-481.
17. Ngo, M. L., Mahdi, F., Kolte, D., Shariat-Madar, Z., Upregulation of prolylcarboxypeptidase (PRCP) in lipopolysaccharide (LPS) treated endothelium promotes inflammation. J. Inflamm. (Lond) 2009, 6, 3.
18. Wallingford, N., Perroud, B., Gao, Q., Coppola, A. et al., Prolylcarboxypeptidase regulates food intake by inactivating alpha-MSH in rodents. J. Clin. Invest. 2009, 119, 2291-2303.
19. Yates, N. A., Deyanova, E. G., Geissler, W., Wiener, M. C. et al., Identification of peptidase substrates in human plasma by FTMS based differential mass spectrometry. Int. J. Mass. Spec. 2007, 259, 174-183.
20. Tammen, H., Schulte, I., Hess, R., Menzel, C. et al., Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Proteomics 2005, 5, 3414-3422. (Pubitemid 41192047)
21. Valdenaire, O., Giller, T., Breu, V., Ardati, A. et al., A new family of orphan G protein-coupled receptors predominantly expressed in the brain. FEBS Lett. 1998, 424, 193-196.
22. Warne, T., Serrano-Vega, M. J., Baker, J. G., Moukhametzianov, R. et al., Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 2008, 454, 486-491.